Provided is an aqueous ophthalmic solution comprising hyaluronic acid or a salt thereof at a concentration of 0.03-0.5% (w/v), propylene glycol at a concentration of 0.1-1.0% (w/v), benzalkonium chloride at a concentration of 0.001-0.002% (w/v) as a preservative and an ionic tonicity agent at such a concentration that the osmotic pressure ratio of the ophthalmic solution becomes 0.9-1.1. Preferred ionic tonicity agents include sodium chloride, calcium chloride and magnesium chloride. The solution is suitable for the treatment of dry eyes.